Two Quartalies ago we heard that PAR have the aim of activating some 120 clinical sites, at that stage they had 102 of them activated:
In the last quarterly they achieved it, all 120 sites activated: In my opinion, the answer is yes, it will assist them in ramping up quickly once we get a green light. I as a shareholder want a lot of things, but hanging around for recruitment and enrolment and the rest...gee why not get whatever we can of that outta the way now!
I know we get frustrated with some things that take longer and the quiet times..and the SP (ugh)...but I'm also glad there are things progressing here....I also know that Cash question is looming, I also think its further away when we have to really address it. The dosing will level off in at least the next Quarter or two...and that's one of the larger imposts...
In terms of recruitment, there is more to it...the EAP alumni program is also feeding into the screening and filtering into the potential recruitment...
We have seen that the data set from the Ex pro footballers are higher than the run of your mill average recruited OA patient, compared to the general population as it were...
This is all preparatory works that they may as well do now and get it ready so they can get a bit more of that sprinter's acceleration and stabilisation from the starting block...
Yes of course we also need to wait till the starters gun is fired (the Authorities discussions happen and we know exactly what they want and how to proceed...any final adjustments, any possible recruitment numbers adjustments too...).
I remember when we had that interview with a Clinical Trial expert a few years ago, he said to us...."Watch recruitment numbers"..."If they start to drop or slow down, thats a red flag"....
I see that our programs (002 Stage 1, MPS) are roughly on track...the Dosing Study is just about done....117 x 4...maybe a few more to cater and handle for any drop outs...the test is when the MED (Minimal Effective Dosing) is declared, we know our Stage 1 is done....then we get to chatting to you know who for a start in Stage 2 and our confirmatory.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)